Search Browse Earnings

Dare Bioscience, Inc. — SlamSEC

Dare Bioscience, Inc.

Nasdaq:DARE

Pharmaceutical Preparations·SAN DIEGO, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$2.8M

FY 2024

Adj. EBITDA

-$30.8M

-1097.4% margin

FY 2024

Net Income

-$30.2M

-1074.2% margin

FY 2024

EPS (Diluted)

-$4.15

FY 2024

Stock Price

$1.53

+0.0%

2026-03-09

52W Range

$1.52 – $9.19

P/E Ratio

-0.4x

Market Cap

$21.9M

Cash

$10.5M

FY 2024

Total Debt

$367,285

FY 2021

Net Cash

$10.1M

FY 2021

Enterprise Value

$11.8M

Debt / EBITDA

0.3x

FY 2024

EV / EBITDA

-0.4x

Employees

—